How aca­d­e­m­ic cen­ters are try­ing to keep their promis­ing drug dis­cov­er­ies out of the ‘val­ley of death’

Scripps Re­search hatch­es med­i­cines. Now, it’s look­ing to spark some­thing else: a mod­el for fi­nan­cial in­de­pen­dence.

The bio­med­ical in­sti­tute has car­ried pro­grams in­to clin­i­cal tri­als, and else­where, the Uni­ver­si­ty of Texas MD An­der­son Can­cer Cen­ter is co-de­vel­op­ing com­pa­nies.

No longer be­hold­en to ear­ly-stage pacts with phar­ma­ceu­ti­cals, aca­d­e­m­ic cen­ters are try­ing to do a bet­ter job cap­i­tal­iz­ing on their sci­ence. The goal is to ease their re­liance on gov­ern­ment fund­ing and over­come the “val­ley of death” in which promis­ing re­search lan­guish­es.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER